SPRO financials

Spero Therapeutics (SPRO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

SPRO income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$66.80M–$6.31M$8.57M0.15
2024$47.98M–-$73.36M-$68.57M-1.27
2023$103.78M–$21.48M$22.81M0.43
2022$53.51M–-$42.20M-$46.41M-1.23
2021$18.26M–-$87.97M-$89.76M-2.91
2020$9.33M–-$79.11M-$78.83M-3.52